• Practical Use of the Annexin V-FITC/PI Apoptosis Assay Kit (

  2026-05-15

  The Annexin V-FITC/PI Apoptosis Assay Kit addresses the need for rapid, discrimination-based detection of early and late apoptotic cells in flow cytometry or fluorescence microscopy workflows. It is best suited for basic research applications in apoptosis analysis, not for clinical or diagnostic use. Researchers should be aware of its technical boundaries and storage requirements before integrating it into their protocols.

• Luminescent ATP Detection Assay Kit: Precision in GBM Metabo

  2026-05-15

  The Luminescent ATP Detection Assay Kit empowers researchers to quantify cellular ATP with unrivaled sensitivity, streamlining workflows for metabolic research in glioblastoma and beyond. This firefly luciferase ATP assay uniquely supports direct, reproducible energy mapping in complex biological samples while remaining fully compatible with downstream protein analyses.

• ML385: Precision NRF2 Inhibitor for Cancer & Ferroptosis Ass

  2026-05-14

  ML385 distinguishes itself as a highly selective NRF2 inhibitor, enabling rigorous dissection of therapeutic resistance and ferroptosis in cancer and neurodegenerative models. This guide translates recent in vivo breakthroughs—such as the reversal of neuroprotection by ML385—into protocol-ready workflows and troubleshooting strategies.

• Fluorescein Tyramide: Unlocking Signal Amplification in Neur

  2026-05-14

  Fluorescein Tyramide stands out for its ability to reveal low-abundance molecular targets in neurobiological research, especially when standard fluorescent labeling falls short. By leveraging tyramide signal amplification, researchers achieve both higher sensitivity and reproducibility in immunohistochemistry, in situ hybridization, and flow cytometry workflows.

• ML385 and NRF2 Inhibition: Unveiling New Frontiers in Redox

  2026-05-13

  Explore how ML385, a potent NRF2 inhibitor, is revolutionizing oxidative stress modulation and therapeutic resistance research. This article offers unique insight into NRF2-ferroptosis interplay and practical assay guidance beyond standard cancer protocols.

• Annexin V-FITC/PI Apoptosis Assay Kit: Applied Workflows & I

  2026-05-13

  Unlock high-fidelity apoptosis detection with the Annexin V-FITC/PI Apoptosis Assay Kit, enabling robust discrimination of early and late apoptotic events in translational and mechanistic studies. This guide delivers stepwise workflows, troubleshooting expertise, and actionable insights inspired by cutting-edge renal amyloidosis research.

• QPRT Drives Breast Cancer Invasion via P2Y11-Mediated Signal

  2026-05-12

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) upregulation enhances breast cancer invasiveness through myosin light chain phosphorylation, implicating purinergic P2Y11 receptor signaling as a mechanistic link. Inhibiting P2Y11 reverses these effects, highlighting new experimental strategies for dissecting metastatic pathways in oncology research.

• Cationic Lipid Composition Tunes mRNA Lipoplex Immunogenicit

  2026-05-12

  This study systematically evaluates how different cationic and neutral lipid combinations in lipoplex formulations influence antibody production and transgene expression following systemic mRNA delivery in mice. The findings underscore the importance of lipid selection for optimizing vaccine efficacy and provide actionable insights for mRNA delivery system design.

• Reliable Cell Proliferation Assays with Cell Counting Kit-8

  2026-05-11

  This article addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity measurement, demonstrating how the Cell Counting Kit-8 (CCK-8) (SKU K1018) delivers reproducible, sensitive, and user-friendly results. Drawing on practical scenarios, protocol optimization, and vendor selection criteria, it provides actionable guidance for biomedical researchers seeking robust data with CCK-8.

• Triacetin in Experimental Metabolism: Protocols and Troubles

  2026-05-11

  Triacetin (glyceryl triacetate) is redefining metabolic and oncology research through its dual roles as a substrate and signaling molecule. This guide translates cutting-edge evidence into stepwise protocols, advanced use-cases, and practical troubleshooting, making Triacetin from APExBIO a preferred reagent in high-impact laboratory workflows.

• Perifosine (KRX-0401): Advanced Workflows in Apoptosis and R

  2026-05-10

  Perifosine (KRX-0401) is a synthetic alkylphospholipid Akt inhibitor uniquely positioned for both apoptosis assays and radiation sensitization studies in cancer research. This guide translates cutting-edge findings and validated protocols into actionable, troubleshooting-rich workflows, spotlighting APExBIO’s Perifosine as a benchmark tool for Akt/mTOR pathway interrogation.

• Annexin V-FITC/PI Apoptosis Assay Kit: Enhanced Decision-Mak

  2026-05-09

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit enables precise, evidence-driven differentiation of apoptotic stages in cancer research. This article uniquely connects advanced assay design with translational choices in oncology, integrating new reference findings and practical protocol guidance.

• AMPK Modulation Mitigates Airway Inflammation in Obesity-Lin

  2026-05-09

  This study elucidates how AMPK activation suppresses M1 macrophage polarization via the JAK2/STAT3 pathway, thereby attenuating airway inflammation in obesity-related asthma. The findings highlight a mechanistic link between metabolic signaling and immune cell behavior, informing new directions for targeted intervention in refractory asthma phenotypes.

• Nocodazole: Precision Microtubule Polymerization Inhibitor W

  2026-05-08

  Nocodazole from APExBIO empowers researchers to precisely manipulate microtubule dynamics for cell cycle, trafficking, and cancer research workflows. This article provides actionable protocols, troubleshooting strategies, and highlights new frontiers inspired by α-tubulin lactylation to optimize your experimental outcomes.

• Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistan

  2026-05-07

  Tigecycline is a first-in-class glycylcycline antibiotic with proven efficacy against multidrug-resistant bacteria. It acts as a 30S ribosomal subunit inhibitor, demonstrating high potency in both in vitro and in vivo models. This article details its mechanism, evidence base, and protocol parameters for research applications.

11658 records 4/778 page Previous Next 12345 下5页 Last page